Dilini Christina Ranasinghe: Paediatric TPE Is Not Simply Adult TPE in a Smaller Patient
Dilini Christina Ranasinghe, Registrar in Transfusion Medicine at National Blood Centre, shared a post on LinkedIn:
“Paediatric TPE is not simply ‘adult TPE in a smaller patient’
Therapeutic plasma exchange (TPE) in children requires a different level of procedural planning and vigilance.
Key paediatric considerations include:
Extracorporeal volume and blood priming
In children, the circuit volume may represent a significant proportion of total blood volume. Initiating TPE with a saline-primed circuit can lead to haemodilution and hypotension. Blood priming with compatible red cells helps maintain haemodynamic stability and improves tolerance.
Vascular access and line position
Central lines may be malpositioned into unintended vessels or advanced too far due to smaller anatomy. This can lead to poor flow, ineffective exchange, or arrhythmias if the tip irritates the atrial wall — making confirmation of position with imaging essential before starting TPE.
Continuous rather than intermittent exchange
Children tolerate rapid intravascular shifts poorly. A controlled, continuous exchange allows gradual removal and replacement, improving haemodynamic stability.
Continuous monitoring and vigilance
With limited physiological reserve, deterioration can be rapid.
Close monitoring of haemodynamics, electrolytes (especially calcium), access pressures, and clinical status is essential.
Early recognition of subtle changes is key to preventing significant complications.
Team coordination
Safe paediatric TPE requires coordination between paediatric specialties, transfusion medicine, ICU teams when required, and microbiology, across all staff categories — ensuring safe delivery in different care settings.
In paediatric TPE, safety lies in anticipating physiological changes and responding before instability develops.”

Stay updated with Hemostasis Today.
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?